Pages that link to "Q33293609"

The following pages link to Nortriptyline delays disease onset in models of chronic neurodegeneration (Q33293609):

Displaying 33 items.

• Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II. (Q27005950) (← links)
• Therapeutic neuroprotective agents for amyotrophic lateral sclerosis (Q27015029) (← links)
• Amitriptyline improves motor function via enhanced neurotrophin signaling and mitochondrial functions in the murine N171-82Q Huntington disease model. (Q27314860) (← links)
• High throughput screening for neurodegeneration and complex disease phenotypes (Q33323473) (← links)
• Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease (Q33478327) (← links)
• The antiapoptotic activity of melatonin in neurodegenerative diseases (Q33757816) (← links)
• Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. (Q33913550) (← links)
• Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy (Q34222849) (← links)
• Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis (Q34640994) (← links)
• Chronic amitriptyline treatment attenuates nigrostriatal degeneration and significantly alters trophic support in a rat model of parkinsonism (Q35089378) (← links)
• Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system (Q35243291) (← links)
• Mitochondrial energetics and therapeutics (Q35632864) (← links)
• Modeling mitochondrial dysfunctions in the brain: from mice to men. (Q35754400) (← links)
• Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis (Q35899260) (← links)
• Promethazine protects against 3-nitropropionic acid-induced neurotoxicity. (Q36253348) (← links)
• Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis (Q36299228) (← links)
• Mitochondria in neuroplasticity and neurological disorders (Q37216404) (← links)
• Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications (Q37348421) (← links)
• Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease (Q37607467) (← links)
• Connectivity between mitochondrial functions and psychiatric disorders (Q37854101) (← links)
• Neuroprotective effects of psychotropic drugs in Huntington's disease (Q38163877) (← links)
• N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis (Q38868878) (← links)
• Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders. (Q38931373) (← links)
• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease (Q40299879) (← links)
• Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease (Q41821958) (← links)
• Cytosolic phospholipase A₂ inhibition is involved in the protective effect of nortriptyline in primary astrocyte cultures exposed to combined oxygen-glucose deprivation (Q42794544) (← links)
• Treadmill gait analysis characterizes gait alterations in Parkinson's disease and amyotrophic lateral sclerosis mouse models (Q43244203) (← links)
• Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration (Q46220981) (← links)
• Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis (Q46643762) (← links)
• Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder (Q49912084) (← links)
• Mitochondrial permeability transition pore: a potential drug target for neurodegeneration (Q57170869) (← links)
• Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction (Q59136651) (← links)
• Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration (Q92637315) (← links)